Jointown Pharmaceutical Group Co., Ltd Reports Earnings Results for the First Quarter Ended March 31, 2022
April 25, 2022 at 06:23 am
Share
Jointown Pharmaceutical Group Co., Ltd reported earnings results for the first quarter ended March 31, 2022. For the first quarter, the company reported sales was CNY 35,150.35 million compared to CNY 32,628.93 million a year ago. Revenue was CNY 35,150.35 million compared to CNY 32,628.93 million a year ago. Net income was CNY 452.33 million compared to CNY 760.02 million a year ago. Basic earnings per share from continuing operations was CNY 0.23 compared to CNY 0.4 a year ago. Diluted earnings per share from continuing operations was CNY 0.23 compared to CNY 0.39 a year ago.
Jointown Pharmaceutical Group Co., Ltd. is principally engaged in the wholesaling and retailing of pharmaceuticals and medical equipments. The Company is also engaged in the research, development and production of drugs, as well as the provision of relevant value-added services. The Companyâs products mainly include western medicines, proprietary Chinese medicines, Chinese medicine pieces, Chinese herbal medicines, medical equipments, health care products, cosmetics, among others. The Company mainly provides services to direct sales or franchise stores through its retailing businesses.